nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—F2—Alzheimer's disease	0.311	0.553	CbGaD
Captopril—ACE—Alzheimer's disease	0.163	0.289	CbGaD
Captopril—CYP2D6—Alzheimer's disease	0.0891	0.158	CbGaD
Captopril—CYP2D6—Rivastigmine—Alzheimer's disease	0.0602	0.432	CbGbCtD
Captopril—CYP2D6—Donepezil—Alzheimer's disease	0.0481	0.345	CbGbCtD
Captopril—CYP2D6—Galantamine—Alzheimer's disease	0.031	0.223	CbGbCtD
Captopril—REN—blood vessel—Alzheimer's disease	0.00391	0.0713	CbGeAlD
Captopril—MMP2—blood vessel—Alzheimer's disease	0.0036	0.0655	CbGeAlD
Captopril—MMP9—blood vessel—Alzheimer's disease	0.00313	0.057	CbGeAlD
Captopril—LTA4H—embryo—Alzheimer's disease	0.00302	0.0551	CbGeAlD
Captopril—F2—blood vessel—Alzheimer's disease	0.00273	0.0497	CbGeAlD
Captopril—LTA4H—forebrain—Alzheimer's disease	0.00267	0.0487	CbGeAlD
Captopril—LTA4H—telencephalon—Alzheimer's disease	0.00246	0.0448	CbGeAlD
Captopril—MMP2—embryo—Alzheimer's disease	0.00214	0.0391	CbGeAlD
Captopril—REN—forebrain—Alzheimer's disease	0.00206	0.0376	CbGeAlD
Captopril—MMP9—embryo—Alzheimer's disease	0.00187	0.034	CbGeAlD
Captopril—ACE—blood vessel—Alzheimer's disease	0.00167	0.0304	CbGeAlD
Captopril—LTA4H—nervous system—Alzheimer's disease	0.00145	0.0264	CbGeAlD
Captopril—LTA4H—central nervous system—Alzheimer's disease	0.0014	0.0255	CbGeAlD
Captopril—LTA4H—cerebellum—Alzheimer's disease	0.00137	0.0249	CbGeAlD
Captopril—REN—nervous system—Alzheimer's disease	0.00112	0.0204	CbGeAlD
Captopril—LTA4H—brain—Alzheimer's disease	0.00111	0.0202	CbGeAlD
Captopril—REN—central nervous system—Alzheimer's disease	0.00108	0.0197	CbGeAlD
Captopril—REN—cerebellum—Alzheimer's disease	0.00105	0.0192	CbGeAlD
Captopril—MMP2—nervous system—Alzheimer's disease	0.00103	0.0188	CbGeAlD
Captopril—ACE—embryo—Alzheimer's disease	0.000994	0.0181	CbGeAlD
Captopril—MMP2—central nervous system—Alzheimer's disease	0.000992	0.0181	CbGeAlD
Captopril—Enalapril—ACE—Alzheimer's disease	0.000943	1	CrCbGaD
Captopril—MMP9—nervous system—Alzheimer's disease	0.000896	0.0163	CbGeAlD
Captopril—ACE—forebrain—Alzheimer's disease	0.000879	0.016	CbGeAlD
Captopril—MMP9—central nervous system—Alzheimer's disease	0.000862	0.0157	CbGeAlD
Captopril—REN—brain—Alzheimer's disease	0.000856	0.0156	CbGeAlD
Captopril—ACE—telencephalon—Alzheimer's disease	0.000809	0.0147	CbGeAlD
Captopril—MMP2—brain—Alzheimer's disease	0.000787	0.0143	CbGeAlD
Captopril—F2—nervous system—Alzheimer's disease	0.000781	0.0142	CbGeAlD
Captopril—F2—central nervous system—Alzheimer's disease	0.000752	0.0137	CbGeAlD
Captopril—MMP9—brain—Alzheimer's disease	0.000685	0.0125	CbGeAlD
Captopril—Lymphadenopathy—Rivastigmine—Alzheimer's disease	0.000678	0.00602	CcSEcCtD
Captopril—Polyuria—Memantine—Alzheimer's disease	0.000673	0.00598	CcSEcCtD
Captopril—Pollakiuria—Galantamine—Alzheimer's disease	0.000671	0.00596	CcSEcCtD
Captopril—Diabetes mellitus—Rivastigmine—Alzheimer's disease	0.000665	0.00591	CcSEcCtD
Captopril—Cerebrovascular accident—Donepezil—Alzheimer's disease	0.000665	0.00591	CcSEcCtD
Captopril—Polyuria—Rivastigmine—Alzheimer's disease	0.000659	0.00585	CcSEcCtD
Captopril—Weight decreased—Galantamine—Alzheimer's disease	0.000657	0.00584	CcSEcCtD
Captopril—Hyponatraemia—Donepezil—Alzheimer's disease	0.000654	0.00581	CcSEcCtD
Captopril—Renal failure acute—Memantine—Alzheimer's disease	0.00064	0.00569	CcSEcCtD
Captopril—Renal failure—Galantamine—Alzheimer's disease	0.000637	0.00566	CcSEcCtD
Captopril—Renal failure acute—Rivastigmine—Alzheimer's disease	0.000627	0.00557	CcSEcCtD
Captopril—Dermatitis bullous—Memantine—Alzheimer's disease	0.000619	0.0055	CcSEcCtD
Captopril—Ataxia—Donepezil—Alzheimer's disease	0.000612	0.00544	CcSEcCtD
Captopril—SLC22A6—brain—Alzheimer's disease	0.000612	0.0111	CbGeAlD
Captopril—Dermatitis bullous—Rivastigmine—Alzheimer's disease	0.000605	0.00538	CcSEcCtD
Captopril—Cerebrovascular accident—Memantine—Alzheimer's disease	0.000603	0.00536	CcSEcCtD
Captopril—F2—brain—Alzheimer's disease	0.000597	0.0109	CbGeAlD
Captopril—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000595	0.00529	CcSEcCtD
Captopril—Hyponatraemia—Memantine—Alzheimer's disease	0.000594	0.00528	CcSEcCtD
Captopril—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.00059	0.00525	CcSEcCtD
Captopril—ABCB1—blood vessel—Alzheimer's disease	0.000587	0.0107	CbGeAlD
Captopril—Rhinitis—Galantamine—Alzheimer's disease	0.000583	0.00518	CcSEcCtD
Captopril—Hepatitis—Galantamine—Alzheimer's disease	0.000581	0.00517	CcSEcCtD
Captopril—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.000581	0.00516	CcSEcCtD
Captopril—Hallucination—Galantamine—Alzheimer's disease	0.000578	0.00514	CcSEcCtD
Captopril—Muscular weakness—Donepezil—Alzheimer's disease	0.000574	0.0051	CcSEcCtD
Captopril—Cardiac arrest—Memantine—Alzheimer's disease	0.000562	0.005	CcSEcCtD
Captopril—Eosinophilia—Donepezil—Alzheimer's disease	0.000557	0.00495	CcSEcCtD
Captopril—Ataxia—Memantine—Alzheimer's disease	0.000556	0.00494	CcSEcCtD
Captopril—Pancreatitis—Donepezil—Alzheimer's disease	0.000552	0.0049	CcSEcCtD
Captopril—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.00055	0.00489	CcSEcCtD
Captopril—Angina pectoris—Donepezil—Alzheimer's disease	0.000548	0.00487	CcSEcCtD
Captopril—Ataxia—Rivastigmine—Alzheimer's disease	0.000544	0.00483	CcSEcCtD
Captopril—Orthostatic hypotension—Memantine—Alzheimer's disease	0.00054	0.0048	CcSEcCtD
Captopril—Flushing—Galantamine—Alzheimer's disease	0.00054	0.00479	CcSEcCtD
Captopril—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000528	0.00469	CcSEcCtD
Captopril—Muscular weakness—Memantine—Alzheimer's disease	0.000522	0.00463	CcSEcCtD
Captopril—Pollakiuria—Donepezil—Alzheimer's disease	0.00052	0.00462	CcSEcCtD
Captopril—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00051	0.00453	CcSEcCtD
Captopril—Weight decreased—Donepezil—Alzheimer's disease	0.000509	0.00453	CcSEcCtD
Captopril—Bronchospasm—Memantine—Alzheimer's disease	0.000503	0.00447	CcSEcCtD
Captopril—Pancreatitis—Memantine—Alzheimer's disease	0.000501	0.00445	CcSEcCtD
Captopril—Angina pectoris—Memantine—Alzheimer's disease	0.000498	0.00442	CcSEcCtD
Captopril—Tension—Galantamine—Alzheimer's disease	0.000497	0.00441	CcSEcCtD
Captopril—Dysgeusia—Galantamine—Alzheimer's disease	0.000496	0.0044	CcSEcCtD
Captopril—Renal failure—Donepezil—Alzheimer's disease	0.000493	0.00438	CcSEcCtD
Captopril—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000492	0.00437	CcSEcCtD
Captopril—Nervousness—Galantamine—Alzheimer's disease	0.000492	0.00437	CcSEcCtD
Captopril—Pancreatitis—Rivastigmine—Alzheimer's disease	0.00049	0.00436	CcSEcCtD
Captopril—Jaundice—Donepezil—Alzheimer's disease	0.000489	0.00435	CcSEcCtD
Captopril—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000487	0.00433	CcSEcCtD
Captopril—Pancytopenia—Memantine—Alzheimer's disease	0.000485	0.00431	CcSEcCtD
Captopril—Neutropenia—Memantine—Alzheimer's disease	0.000478	0.00425	CcSEcCtD
Captopril—ACE—nervous system—Alzheimer's disease	0.000477	0.0087	CbGeAlD
Captopril—Vision blurred—Galantamine—Alzheimer's disease	0.000477	0.00424	CcSEcCtD
Captopril—Pollakiuria—Memantine—Alzheimer's disease	0.000472	0.0042	CcSEcCtD
Captopril—Erectile dysfunction—Memantine—Alzheimer's disease	0.000471	0.00418	CcSEcCtD
Captopril—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00047	0.00417	CcSEcCtD
Captopril—Anaemia—Galantamine—Alzheimer's disease	0.000468	0.00416	CcSEcCtD
Captopril—Weight decreased—Memantine—Alzheimer's disease	0.000462	0.00411	CcSEcCtD
Captopril—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000462	0.0041	CcSEcCtD
Captopril—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.00046	0.00409	CcSEcCtD
Captopril—ACE—central nervous system—Alzheimer's disease	0.00046	0.00837	CbGeAlD
Captopril—Malaise—Galantamine—Alzheimer's disease	0.000456	0.00406	CcSEcCtD
Captopril—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000456	0.00406	CcSEcCtD
Captopril—Syncope—Galantamine—Alzheimer's disease	0.000454	0.00403	CcSEcCtD
Captopril—Weight decreased—Rivastigmine—Alzheimer's disease	0.000452	0.00402	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000452	0.00401	CcSEcCtD
Captopril—Rhinitis—Donepezil—Alzheimer's disease	0.000452	0.00401	CcSEcCtD
Captopril—Hepatitis—Donepezil—Alzheimer's disease	0.000451	0.004	CcSEcCtD
Captopril—Hallucination—Donepezil—Alzheimer's disease	0.000448	0.00398	CcSEcCtD
Captopril—Renal failure—Memantine—Alzheimer's disease	0.000448	0.00398	CcSEcCtD
Captopril—Palpitations—Galantamine—Alzheimer's disease	0.000447	0.00397	CcSEcCtD
Captopril—Pharyngitis—Donepezil—Alzheimer's disease	0.000447	0.00397	CcSEcCtD
Captopril—Loss of consciousness—Galantamine—Alzheimer's disease	0.000445	0.00395	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000442	0.00393	CcSEcCtD
Captopril—Cough—Galantamine—Alzheimer's disease	0.000442	0.00392	CcSEcCtD
Captopril—Renal failure—Rivastigmine—Alzheimer's disease	0.000438	0.00389	CcSEcCtD
Captopril—Chest pain—Galantamine—Alzheimer's disease	0.000431	0.00383	CcSEcCtD
Captopril—Arthralgia—Galantamine—Alzheimer's disease	0.000431	0.00383	CcSEcCtD
Captopril—Myalgia—Galantamine—Alzheimer's disease	0.000431	0.00383	CcSEcCtD
Captopril—CYP2D6—forebrain—Alzheimer's disease	0.00043	0.00784	CbGeAlD
Captopril—Discomfort—Galantamine—Alzheimer's disease	0.000426	0.00378	CcSEcCtD
Captopril—Agranulocytosis—Memantine—Alzheimer's disease	0.000425	0.00378	CcSEcCtD
Captopril—Dry mouth—Galantamine—Alzheimer's disease	0.000421	0.00374	CcSEcCtD
Captopril—Confusional state—Galantamine—Alzheimer's disease	0.000416	0.0037	CcSEcCtD
Captopril—Rhinitis—Memantine—Alzheimer's disease	0.00041	0.00364	CcSEcCtD
Captopril—Hepatitis—Memantine—Alzheimer's disease	0.000409	0.00364	CcSEcCtD
Captopril—Hallucination—Memantine—Alzheimer's disease	0.000407	0.00362	CcSEcCtD
Captopril—Shock—Galantamine—Alzheimer's disease	0.000406	0.00361	CcSEcCtD
Captopril—Pharyngitis—Memantine—Alzheimer's disease	0.000406	0.00361	CcSEcCtD
Captopril—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000404	0.00359	CcSEcCtD
Captopril—Tachycardia—Galantamine—Alzheimer's disease	0.000403	0.00358	CcSEcCtD
Captopril—Rhinitis—Rivastigmine—Alzheimer's disease	0.000401	0.00357	CcSEcCtD
Captopril—Hepatitis—Rivastigmine—Alzheimer's disease	0.0004	0.00356	CcSEcCtD
Captopril—Hallucination—Rivastigmine—Alzheimer's disease	0.000398	0.00354	CcSEcCtD
Captopril—Alopecia—Donepezil—Alzheimer's disease	0.000398	0.00354	CcSEcCtD
Captopril—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000397	0.00353	CcSEcCtD
Captopril—CYP2D6—telencephalon—Alzheimer's disease	0.000396	0.00721	CbGeAlD
Captopril—Anorexia—Galantamine—Alzheimer's disease	0.000394	0.0035	CcSEcCtD
Captopril—Erythema multiforme—Memantine—Alzheimer's disease	0.000387	0.00344	CcSEcCtD
Captopril—Hypotension—Galantamine—Alzheimer's disease	0.000386	0.00343	CcSEcCtD
Captopril—Tension—Donepezil—Alzheimer's disease	0.000385	0.00342	CcSEcCtD
Captopril—Dysgeusia—Donepezil—Alzheimer's disease	0.000384	0.00341	CcSEcCtD
Captopril—ALB—brain—Alzheimer's disease	0.000381	0.00695	CbGeAlD
Captopril—Nervousness—Donepezil—Alzheimer's disease	0.000381	0.00338	CcSEcCtD
Captopril—Flushing—Memantine—Alzheimer's disease	0.00038	0.00337	CcSEcCtD
Captopril—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000378	0.00336	CcSEcCtD
Captopril—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000376	0.00334	CcSEcCtD
Captopril—Insomnia—Galantamine—Alzheimer's disease	0.000374	0.00332	CcSEcCtD
Captopril—Flushing—Rivastigmine—Alzheimer's disease	0.000371	0.0033	CcSEcCtD
Captopril—Paraesthesia—Galantamine—Alzheimer's disease	0.000371	0.0033	CcSEcCtD
Captopril—Vision blurred—Donepezil—Alzheimer's disease	0.00037	0.00328	CcSEcCtD
Captopril—Somnolence—Galantamine—Alzheimer's disease	0.000367	0.00326	CcSEcCtD
Captopril—ACE—brain—Alzheimer's disease	0.000365	0.00665	CbGeAlD
Captopril—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000364	0.00323	CcSEcCtD
Captopril—Dyspepsia—Galantamine—Alzheimer's disease	0.000364	0.00323	CcSEcCtD
Captopril—Anaemia—Donepezil—Alzheimer's disease	0.000362	0.00322	CcSEcCtD
Captopril—Alopecia—Memantine—Alzheimer's disease	0.000361	0.00321	CcSEcCtD
Captopril—Decreased appetite—Galantamine—Alzheimer's disease	0.000359	0.00319	CcSEcCtD
Captopril—Fatigue—Galantamine—Alzheimer's disease	0.000356	0.00316	CcSEcCtD
Captopril—Malaise—Donepezil—Alzheimer's disease	0.000354	0.00314	CcSEcCtD
Captopril—Alopecia—Rivastigmine—Alzheimer's disease	0.000354	0.00314	CcSEcCtD
Captopril—Constipation—Galantamine—Alzheimer's disease	0.000353	0.00314	CcSEcCtD
Captopril—Syncope—Donepezil—Alzheimer's disease	0.000352	0.00313	CcSEcCtD
Captopril—ABCB1—embryo—Alzheimer's disease	0.00035	0.00638	CbGeAlD
Captopril—Tension—Memantine—Alzheimer's disease	0.000349	0.00311	CcSEcCtD
Captopril—Dysgeusia—Memantine—Alzheimer's disease	0.000349	0.0031	CcSEcCtD
Captopril—Nervousness—Memantine—Alzheimer's disease	0.000346	0.00307	CcSEcCtD
Captopril—Loss of consciousness—Donepezil—Alzheimer's disease	0.000345	0.00306	CcSEcCtD
Captopril—Cough—Donepezil—Alzheimer's disease	0.000342	0.00304	CcSEcCtD
Captopril—Tension—Rivastigmine—Alzheimer's disease	0.000342	0.00304	CcSEcCtD
Captopril—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000341	0.00303	CcSEcCtD
Captopril—Feeling abnormal—Galantamine—Alzheimer's disease	0.00034	0.00302	CcSEcCtD
Captopril—Nervousness—Rivastigmine—Alzheimer's disease	0.000338	0.00301	CcSEcCtD
Captopril—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000338	0.003	CcSEcCtD
Captopril—Vision blurred—Memantine—Alzheimer's disease	0.000336	0.00298	CcSEcCtD
Captopril—Myalgia—Donepezil—Alzheimer's disease	0.000334	0.00297	CcSEcCtD
Captopril—Chest pain—Donepezil—Alzheimer's disease	0.000334	0.00297	CcSEcCtD
Captopril—Arthralgia—Donepezil—Alzheimer's disease	0.000334	0.00297	CcSEcCtD
Captopril—Ill-defined disorder—Memantine—Alzheimer's disease	0.00033	0.00294	CcSEcCtD
Captopril—Discomfort—Donepezil—Alzheimer's disease	0.00033	0.00293	CcSEcCtD
Captopril—Anaemia—Memantine—Alzheimer's disease	0.000329	0.00292	CcSEcCtD
Captopril—Vision blurred—Rivastigmine—Alzheimer's disease	0.000328	0.00292	CcSEcCtD
Captopril—Dry mouth—Donepezil—Alzheimer's disease	0.000327	0.0029	CcSEcCtD
Captopril—Abdominal pain—Galantamine—Alzheimer's disease	0.000326	0.0029	CcSEcCtD
Captopril—Body temperature increased—Galantamine—Alzheimer's disease	0.000326	0.0029	CcSEcCtD
Captopril—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000323	0.00287	CcSEcCtD
Captopril—Confusional state—Donepezil—Alzheimer's disease	0.000323	0.00287	CcSEcCtD
Captopril—Anaemia—Rivastigmine—Alzheimer's disease	0.000322	0.00286	CcSEcCtD
Captopril—Malaise—Memantine—Alzheimer's disease	0.000321	0.00285	CcSEcCtD
Captopril—Syncope—Memantine—Alzheimer's disease	0.000319	0.00284	CcSEcCtD
Captopril—Shock—Donepezil—Alzheimer's disease	0.000315	0.0028	CcSEcCtD
Captopril—Palpitations—Memantine—Alzheimer's disease	0.000315	0.0028	CcSEcCtD
Captopril—Malaise—Rivastigmine—Alzheimer's disease	0.000314	0.00279	CcSEcCtD
Captopril—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000313	0.00278	CcSEcCtD
Captopril—Loss of consciousness—Memantine—Alzheimer's disease	0.000313	0.00278	CcSEcCtD
Captopril—Syncope—Rivastigmine—Alzheimer's disease	0.000312	0.00278	CcSEcCtD
Captopril—Cough—Memantine—Alzheimer's disease	0.000311	0.00276	CcSEcCtD
Captopril—ABCB1—forebrain—Alzheimer's disease	0.00031	0.00564	CbGeAlD
Captopril—Palpitations—Rivastigmine—Alzheimer's disease	0.000308	0.00274	CcSEcCtD
Captopril—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000306	0.00272	CcSEcCtD
Captopril—Anorexia—Donepezil—Alzheimer's disease	0.000305	0.00271	CcSEcCtD
Captopril—Cough—Rivastigmine—Alzheimer's disease	0.000304	0.0027	CcSEcCtD
Captopril—Myalgia—Memantine—Alzheimer's disease	0.000303	0.00269	CcSEcCtD
Captopril—Chest pain—Memantine—Alzheimer's disease	0.000303	0.00269	CcSEcCtD
Captopril—Arthralgia—Memantine—Alzheimer's disease	0.000303	0.00269	CcSEcCtD
Captopril—Discomfort—Memantine—Alzheimer's disease	0.0003	0.00266	CcSEcCtD
Captopril—Hypotension—Donepezil—Alzheimer's disease	0.000299	0.00266	CcSEcCtD
Captopril—Myalgia—Rivastigmine—Alzheimer's disease	0.000297	0.00264	CcSEcCtD
Captopril—Chest pain—Rivastigmine—Alzheimer's disease	0.000297	0.00264	CcSEcCtD
Captopril—Arthralgia—Rivastigmine—Alzheimer's disease	0.000297	0.00264	CcSEcCtD
Captopril—Dry mouth—Memantine—Alzheimer's disease	0.000296	0.00263	CcSEcCtD
Captopril—Asthenia—Galantamine—Alzheimer's disease	0.000296	0.00263	CcSEcCtD
Captopril—Confusional state—Memantine—Alzheimer's disease	0.000293	0.0026	CcSEcCtD
Captopril—Discomfort—Rivastigmine—Alzheimer's disease	0.000293	0.0026	CcSEcCtD
Captopril—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000292	0.00259	CcSEcCtD
Captopril—Dry mouth—Rivastigmine—Alzheimer's disease	0.00029	0.00258	CcSEcCtD
Captopril—Insomnia—Donepezil—Alzheimer's disease	0.00029	0.00257	CcSEcCtD
Captopril—Paraesthesia—Donepezil—Alzheimer's disease	0.000287	0.00255	CcSEcCtD
Captopril—Confusional state—Rivastigmine—Alzheimer's disease	0.000287	0.00255	CcSEcCtD
Captopril—Shock—Memantine—Alzheimer's disease	0.000286	0.00254	CcSEcCtD
Captopril—Dyspnoea—Donepezil—Alzheimer's disease	0.000285	0.00254	CcSEcCtD
Captopril—ABCB1—telencephalon—Alzheimer's disease	0.000285	0.00519	CbGeAlD
Captopril—Somnolence—Donepezil—Alzheimer's disease	0.000285	0.00253	CcSEcCtD
Captopril—Thrombocytopenia—Memantine—Alzheimer's disease	0.000285	0.00253	CcSEcCtD
Captopril—Tachycardia—Memantine—Alzheimer's disease	0.000284	0.00252	CcSEcCtD
Captopril—Diarrhoea—Galantamine—Alzheimer's disease	0.000283	0.00251	CcSEcCtD
Captopril—Dyspepsia—Donepezil—Alzheimer's disease	0.000282	0.0025	CcSEcCtD
Captopril—Shock—Rivastigmine—Alzheimer's disease	0.00028	0.00249	CcSEcCtD
Captopril—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000278	0.00247	CcSEcCtD
Captopril—Decreased appetite—Donepezil—Alzheimer's disease	0.000278	0.00247	CcSEcCtD
Captopril—Tachycardia—Rivastigmine—Alzheimer's disease	0.000277	0.00247	CcSEcCtD
Captopril—Anorexia—Memantine—Alzheimer's disease	0.000277	0.00246	CcSEcCtD
Captopril—Fatigue—Donepezil—Alzheimer's disease	0.000276	0.00245	CcSEcCtD
Captopril—Constipation—Donepezil—Alzheimer's disease	0.000274	0.00243	CcSEcCtD
Captopril—Dizziness—Galantamine—Alzheimer's disease	0.000273	0.00243	CcSEcCtD
Captopril—Hypotension—Memantine—Alzheimer's disease	0.000272	0.00241	CcSEcCtD
Captopril—Anorexia—Rivastigmine—Alzheimer's disease	0.000271	0.00241	CcSEcCtD
Captopril—Hypotension—Rivastigmine—Alzheimer's disease	0.000266	0.00236	CcSEcCtD
Captopril—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000265	0.00235	CcSEcCtD
Captopril—Feeling abnormal—Donepezil—Alzheimer's disease	0.000264	0.00234	CcSEcCtD
Captopril—Insomnia—Memantine—Alzheimer's disease	0.000263	0.00234	CcSEcCtD
Captopril—Vomiting—Galantamine—Alzheimer's disease	0.000263	0.00233	CcSEcCtD
Captopril—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000262	0.00233	CcSEcCtD
Captopril—Paraesthesia—Memantine—Alzheimer's disease	0.000261	0.00232	CcSEcCtD
Captopril—Rash—Galantamine—Alzheimer's disease	0.00026	0.00231	CcSEcCtD
Captopril—Dermatitis—Galantamine—Alzheimer's disease	0.00026	0.00231	CcSEcCtD
Captopril—Dyspnoea—Memantine—Alzheimer's disease	0.000259	0.0023	CcSEcCtD
Captopril—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000259	0.0023	CcSEcCtD
Captopril—Headache—Galantamine—Alzheimer's disease	0.000259	0.0023	CcSEcCtD
Captopril—Somnolence—Memantine—Alzheimer's disease	0.000258	0.0023	CcSEcCtD
Captopril—Insomnia—Rivastigmine—Alzheimer's disease	0.000257	0.00229	CcSEcCtD
Captopril—Dyspepsia—Memantine—Alzheimer's disease	0.000256	0.00227	CcSEcCtD
Captopril—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000255	0.00227	CcSEcCtD
Captopril—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000253	0.00225	CcSEcCtD
Captopril—Body temperature increased—Donepezil—Alzheimer's disease	0.000253	0.00225	CcSEcCtD
Captopril—Abdominal pain—Donepezil—Alzheimer's disease	0.000253	0.00225	CcSEcCtD
Captopril—Somnolence—Rivastigmine—Alzheimer's disease	0.000253	0.00225	CcSEcCtD
Captopril—Decreased appetite—Memantine—Alzheimer's disease	0.000253	0.00225	CcSEcCtD
Captopril—Fatigue—Memantine—Alzheimer's disease	0.000251	0.00223	CcSEcCtD
Captopril—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00025	0.00222	CcSEcCtD
Captopril—Constipation—Memantine—Alzheimer's disease	0.000249	0.00221	CcSEcCtD
Captopril—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000247	0.0022	CcSEcCtD
Captopril—Nausea—Galantamine—Alzheimer's disease	0.000245	0.00218	CcSEcCtD
Captopril—Fatigue—Rivastigmine—Alzheimer's disease	0.000245	0.00218	CcSEcCtD
Captopril—Constipation—Rivastigmine—Alzheimer's disease	0.000243	0.00216	CcSEcCtD
Captopril—Feeling abnormal—Memantine—Alzheimer's disease	0.000239	0.00213	CcSEcCtD
Captopril—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000238	0.00211	CcSEcCtD
Captopril—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000234	0.00208	CcSEcCtD
Captopril—CYP2D6—nervous system—Alzheimer's disease	0.000234	0.00426	CbGeAlD
Captopril—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000232	0.00207	CcSEcCtD
Captopril—Body temperature increased—Memantine—Alzheimer's disease	0.00023	0.00204	CcSEcCtD
Captopril—Abdominal pain—Memantine—Alzheimer's disease	0.00023	0.00204	CcSEcCtD
Captopril—Asthenia—Donepezil—Alzheimer's disease	0.00023	0.00204	CcSEcCtD
Captopril—Pruritus—Donepezil—Alzheimer's disease	0.000226	0.00201	CcSEcCtD
Captopril—CYP2D6—central nervous system—Alzheimer's disease	0.000225	0.0041	CbGeAlD
Captopril—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000225	0.002	CcSEcCtD
Captopril—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000225	0.002	CcSEcCtD
Captopril—CYP2D6—cerebellum—Alzheimer's disease	0.00022	0.00401	CbGeAlD
Captopril—Diarrhoea—Donepezil—Alzheimer's disease	0.000219	0.00195	CcSEcCtD
Captopril—Dizziness—Donepezil—Alzheimer's disease	0.000212	0.00188	CcSEcCtD
Captopril—Asthenia—Memantine—Alzheimer's disease	0.000209	0.00185	CcSEcCtD
Captopril—Pruritus—Memantine—Alzheimer's disease	0.000206	0.00183	CcSEcCtD
Captopril—Asthenia—Rivastigmine—Alzheimer's disease	0.000204	0.00181	CcSEcCtD
Captopril—Vomiting—Donepezil—Alzheimer's disease	0.000204	0.00181	CcSEcCtD
Captopril—Rash—Donepezil—Alzheimer's disease	0.000202	0.00179	CcSEcCtD
Captopril—Dermatitis—Donepezil—Alzheimer's disease	0.000202	0.00179	CcSEcCtD
Captopril—Pruritus—Rivastigmine—Alzheimer's disease	0.000201	0.00179	CcSEcCtD
Captopril—Headache—Donepezil—Alzheimer's disease	0.000201	0.00178	CcSEcCtD
Captopril—Diarrhoea—Memantine—Alzheimer's disease	0.000199	0.00177	CcSEcCtD
Captopril—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000195	0.00173	CcSEcCtD
Captopril—Dizziness—Memantine—Alzheimer's disease	0.000192	0.00171	CcSEcCtD
Captopril—Nausea—Donepezil—Alzheimer's disease	0.00019	0.00169	CcSEcCtD
Captopril—Dizziness—Rivastigmine—Alzheimer's disease	0.000188	0.00167	CcSEcCtD
Captopril—Vomiting—Memantine—Alzheimer's disease	0.000185	0.00164	CcSEcCtD
Captopril—Rash—Memantine—Alzheimer's disease	0.000183	0.00163	CcSEcCtD
Captopril—Dermatitis—Memantine—Alzheimer's disease	0.000183	0.00163	CcSEcCtD
Captopril—Headache—Memantine—Alzheimer's disease	0.000182	0.00162	CcSEcCtD
Captopril—Vomiting—Rivastigmine—Alzheimer's disease	0.000181	0.00161	CcSEcCtD
Captopril—Rash—Rivastigmine—Alzheimer's disease	0.000179	0.00159	CcSEcCtD
Captopril—Dermatitis—Rivastigmine—Alzheimer's disease	0.000179	0.00159	CcSEcCtD
Captopril—CYP2D6—brain—Alzheimer's disease	0.000179	0.00325	CbGeAlD
Captopril—Headache—Rivastigmine—Alzheimer's disease	0.000178	0.00158	CcSEcCtD
Captopril—Nausea—Memantine—Alzheimer's disease	0.000173	0.00153	CcSEcCtD
Captopril—Nausea—Rivastigmine—Alzheimer's disease	0.000169	0.0015	CcSEcCtD
Captopril—ABCB1—nervous system—Alzheimer's disease	0.000168	0.00306	CbGeAlD
Captopril—ABCB1—central nervous system—Alzheimer's disease	0.000162	0.00295	CbGeAlD
Captopril—ABCB1—cerebellum—Alzheimer's disease	0.000158	0.00288	CbGeAlD
Captopril—ABCB1—brain—Alzheimer's disease	0.000128	0.00234	CbGeAlD
Captopril—ALB—Hemostasis—TF—Alzheimer's disease	1.48e-05	0.000115	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.47e-05	0.000113	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—APP—Alzheimer's disease	1.46e-05	0.000113	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—F2—Alzheimer's disease	1.45e-05	0.000112	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	1.45e-05	0.000112	CbGpPWpGaD
Captopril—ALB—Metabolism—ATP5A1—Alzheimer's disease	1.44e-05	0.000112	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PSEN2—Alzheimer's disease	1.44e-05	0.000111	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—VEGFA—Alzheimer's disease	1.42e-05	0.00011	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	1.42e-05	0.00011	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CA4—Alzheimer's disease	1.42e-05	0.00011	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CCR5—Alzheimer's disease	1.39e-05	0.000108	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—AKT1—Alzheimer's disease	1.39e-05	0.000107	CbGpPWpGaD
Captopril—MMP9—Axon guidance—IL6—Alzheimer's disease	1.38e-05	0.000107	CbGpPWpGaD
Captopril—ALB—Metabolism—PLD3—Alzheimer's disease	1.38e-05	0.000107	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.38e-05	0.000107	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PLCB1—Alzheimer's disease	1.38e-05	0.000107	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.36e-05	0.000105	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.36e-05	0.000105	CbGpPWpGaD
Captopril—ALB—Hemostasis—GAB2—Alzheimer's disease	1.35e-05	0.000105	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—INS—Alzheimer's disease	1.34e-05	0.000104	CbGpPWpGaD
Captopril—LTA4H—Metabolism—AKT1—Alzheimer's disease	1.34e-05	0.000104	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CA4—Alzheimer's disease	1.34e-05	0.000104	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	1.34e-05	0.000103	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	1.34e-05	0.000103	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PRKCG—Alzheimer's disease	1.33e-05	0.000103	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NPY—Alzheimer's disease	1.32e-05	0.000103	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CCL2—Alzheimer's disease	1.32e-05	0.000102	CbGpPWpGaD
Captopril—ALB—Metabolism—HSD17B10—Alzheimer's disease	1.32e-05	0.000102	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	1.32e-05	0.000102	CbGpPWpGaD
Captopril—ALB—Hemostasis—APP—Alzheimer's disease	1.32e-05	0.000102	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IAPP—Alzheimer's disease	1.32e-05	0.000102	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TGFB1—Alzheimer's disease	1.31e-05	0.000101	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	1.3e-05	0.000101	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—IGF1—Alzheimer's disease	1.3e-05	0.000101	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.29e-05	0.0001	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NGFR—Alzheimer's disease	1.28e-05	9.95e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—TF—Alzheimer's disease	1.28e-05	9.92e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CRH—Alzheimer's disease	1.28e-05	9.9e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP46A1—Alzheimer's disease	1.27e-05	9.85e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IGF1—Alzheimer's disease	1.27e-05	9.85e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	1.27e-05	9.8e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCR5—Alzheimer's disease	1.26e-05	9.77e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	1.26e-05	9.74e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ADAM10—Alzheimer's disease	1.25e-05	9.72e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	1.25e-05	9.7e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.23e-05	9.56e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ND1—Alzheimer's disease	1.23e-05	9.51e-05	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	1.22e-05	9.46e-05	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TNF—Alzheimer's disease	1.22e-05	9.45e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NPS—Alzheimer's disease	1.21e-05	9.38e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PLD3—Alzheimer's disease	1.21e-05	9.35e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.21e-05	9.34e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.2e-05	9.3e-05	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL6—Alzheimer's disease	1.2e-05	9.29e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	1.19e-05	9.24e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTK2B—Alzheimer's disease	1.19e-05	9.2e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—S100B—Alzheimer's disease	1.19e-05	9.19e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	1.16e-05	8.96e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GAB2—Alzheimer's disease	1.16e-05	8.95e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NTRK2—Alzheimer's disease	1.16e-05	8.95e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SST—Alzheimer's disease	1.16e-05	8.95e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CALM1—Alzheimer's disease	1.15e-05	8.92e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GSK3A—Alzheimer's disease	1.15e-05	8.87e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.14e-05	8.81e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IGF2—Alzheimer's disease	1.13e-05	8.75e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APP—Alzheimer's disease	1.13e-05	8.72e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	1.12e-05	8.69e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	1.11e-05	8.63e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.1e-05	8.5e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	1.09e-05	8.46e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IGF1R—Alzheimer's disease	1.09e-05	8.46e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.09e-05	8.45e-05	CbGpPWpGaD
Captopril—F2—Hemostasis—VEGFA—Alzheimer's disease	1.08e-05	8.36e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ND1—Alzheimer's disease	1.08e-05	8.33e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—SOD1—Alzheimer's disease	1.07e-05	8.32e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PLCB1—Alzheimer's disease	1.06e-05	8.23e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.05e-05	8.13e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—LPL—Alzheimer's disease	1.05e-05	8.11e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	1.04e-05	8.04e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MEF2C—Alzheimer's disease	1.04e-05	8.04e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—IGF2—Alzheimer's disease	1.02e-05	7.91e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PRKCG—Alzheimer's disease	1.02e-05	7.88e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.01e-05	7.85e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NGFR—Alzheimer's disease	9.92e-06	7.68e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NGF—Alzheimer's disease	9.92e-06	7.68e-05	CbGpPWpGaD
Captopril—F2—Hemostasis—TGFB1—Alzheimer's disease	9.9e-06	7.67e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CREB1—Alzheimer's disease	9.86e-06	7.63e-05	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—IL6—Alzheimer's disease	9.85e-06	7.63e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ADAM10—Alzheimer's disease	9.69e-06	7.5e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCR5—Alzheimer's disease	9.65e-06	7.47e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCL2—Alzheimer's disease	9.64e-06	7.47e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	9.64e-06	7.46e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	9.46e-06	7.33e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HTR2A—Alzheimer's disease	9.44e-06	7.31e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PRKCG—Alzheimer's disease	9.2e-06	7.13e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—S100B—Alzheimer's disease	9.16e-06	7.09e-05	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—AKT1—Alzheimer's disease	9.09e-06	7.04e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	8.96e-06	6.94e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	8.86e-06	6.86e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CALM1—Alzheimer's disease	8.81e-06	6.82e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—LEP—Alzheimer's disease	8.78e-06	6.8e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—APOE—Alzheimer's disease	8.78e-06	6.8e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IGF2—Alzheimer's disease	8.72e-06	6.75e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CAV1—Alzheimer's disease	8.7e-06	6.73e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	8.62e-06	6.67e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IGF1R—Alzheimer's disease	8.43e-06	6.53e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ESR1—Alzheimer's disease	8.38e-06	6.49e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	8.31e-06	6.43e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—F2—Alzheimer's disease	8.28e-06	6.41e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	8.18e-06	6.33e-05	CbGpPWpGaD
Captopril—F2—Hemostasis—TP53—Alzheimer's disease	8.15e-06	6.31e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOTCH1—Alzheimer's disease	8.1e-06	6.27e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—LPL—Alzheimer's disease	8.09e-06	6.26e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PLAU—Alzheimer's disease	8.05e-06	6.23e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MEF2C—Alzheimer's disease	8.01e-06	6.21e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—CALM1—Alzheimer's disease	7.96e-06	6.16e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—TPI1—Alzheimer's disease	7.91e-06	6.13e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CHAT—Alzheimer's disease	7.91e-06	6.13e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PRKCG—Alzheimer's disease	7.86e-06	6.09e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—CAV1—Alzheimer's disease	7.86e-06	6.09e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	7.85e-06	6.08e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NGF—Alzheimer's disease	7.66e-06	5.93e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	7.62e-06	5.9e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GSK3B—Alzheimer's disease	7.6e-06	5.89e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—MAOB—Alzheimer's disease	7.59e-06	5.88e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CREB1—Alzheimer's disease	7.54e-06	5.84e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	7.51e-06	5.81e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—INS—Alzheimer's disease	7.5e-06	5.81e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—F2—Alzheimer's disease	7.48e-06	5.79e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCR5—Alzheimer's disease	7.45e-06	5.77e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS2—Alzheimer's disease	7.39e-06	5.72e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCL2—Alzheimer's disease	7.38e-06	5.71e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GAPDH—Alzheimer's disease	7.3e-06	5.66e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HTR2A—Alzheimer's disease	7.29e-06	5.65e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IGF1—Alzheimer's disease	7.25e-06	5.62e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	7.22e-06	5.59e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	7.15e-06	5.54e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—A2M—Alzheimer's disease	7.05e-06	5.46e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	7.01e-06	5.43e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CHAT—Alzheimer's disease	6.93e-06	5.37e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TPI1—Alzheimer's disease	6.93e-06	5.37e-05	CbGpPWpGaD
Captopril—F2—Hemostasis—AKT1—Alzheimer's disease	6.88e-06	5.33e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CALM1—Alzheimer's disease	6.8e-06	5.27e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APOE—Alzheimer's disease	6.78e-06	5.25e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—LEP—Alzheimer's disease	6.78e-06	5.25e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CAV1—Alzheimer's disease	6.71e-06	5.2e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MAOB—Alzheimer's disease	6.65e-06	5.15e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOS3—Alzheimer's disease	6.58e-06	5.09e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—IGF1—Alzheimer's disease	6.55e-06	5.08e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CHAT—Alzheimer's disease	6.53e-06	5.06e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TPI1—Alzheimer's disease	6.53e-06	5.06e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ESR1—Alzheimer's disease	6.47e-06	5.01e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GAPDH—Alzheimer's disease	6.4e-06	4.96e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	6.29e-06	4.87e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MAOB—Alzheimer's disease	6.26e-06	4.85e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOTCH1—Alzheimer's disease	6.25e-06	4.84e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—A2M—Alzheimer's disease	6.18e-06	4.79e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	6.18e-06	4.79e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ACHE—Alzheimer's disease	6.14e-06	4.75e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—INPP5D—Alzheimer's disease	6.07e-06	4.7e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	6.03e-06	4.67e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS3—Alzheimer's disease	5.94e-06	4.6e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GSK3B—Alzheimer's disease	5.87e-06	4.55e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—A2M—Alzheimer's disease	5.82e-06	4.51e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CREB1—Alzheimer's disease	5.82e-06	4.51e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—INS—Alzheimer's disease	5.79e-06	4.48e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ENO1—Alzheimer's disease	5.75e-06	4.45e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS1—Alzheimer's disease	5.75e-06	4.45e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL2—Alzheimer's disease	5.7e-06	4.41e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP2D6—Alzheimer's disease	5.64e-06	4.37e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IGF1—Alzheimer's disease	5.6e-06	4.34e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CASP3—Alzheimer's disease	5.58e-06	4.32e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ACHE—Alzheimer's disease	5.38e-06	4.16e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—BCHE—Alzheimer's disease	5.35e-06	4.14e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—INPP5D—Alzheimer's disease	5.31e-06	4.12e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	5.3e-06	4.1e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	5.22e-06	4.04e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAPK8—Alzheimer's disease	5.13e-06	3.97e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOS3—Alzheimer's disease	5.08e-06	3.93e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ACHE—Alzheimer's disease	5.07e-06	3.92e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PLCB1—Alzheimer's disease	5.04e-06	3.91e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS1—Alzheimer's disease	5.04e-06	3.9e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ENO1—Alzheimer's disease	5.04e-06	3.9e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	5.01e-06	3.88e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.95e-06	3.83e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	4.94e-06	3.83e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ABCA1—Alzheimer's disease	4.89e-06	3.79e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ENO1—Alzheimer's disease	4.75e-06	3.68e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	4.75e-06	3.68e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VEGFA—Alzheimer's disease	4.74e-06	3.67e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—BCHE—Alzheimer's disease	4.68e-06	3.63e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PLCB1—Alzheimer's disease	4.42e-06	3.42e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—BCHE—Alzheimer's disease	4.41e-06	3.42e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AKT1—Alzheimer's disease	4.35e-06	3.37e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TGFB1—Alzheimer's disease	4.35e-06	3.37e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CASP3—Alzheimer's disease	4.31e-06	3.34e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ABCA1—Alzheimer's disease	4.28e-06	3.32e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6—Alzheimer's disease	4.28e-06	3.32e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—VEGFA—Alzheimer's disease	4.28e-06	3.32e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PPARGC1A—Alzheimer's disease	4.21e-06	3.26e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—HMOX1—Alzheimer's disease	4.19e-06	3.25e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	4.16e-06	3.23e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	4.04e-06	3.13e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAPK8—Alzheimer's disease	3.96e-06	3.07e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AKT1—Alzheimer's disease	3.95e-06	3.06e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TGFB1—Alzheimer's disease	3.93e-06	3.04e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—LPL—Alzheimer's disease	3.84e-06	2.97e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	3.69e-06	2.86e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HMOX1—Alzheimer's disease	3.68e-06	2.85e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VEGFA—Alzheimer's disease	3.66e-06	2.83e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—Alzheimer's disease	3.58e-06	2.77e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	3.48e-06	2.69e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	3.46e-06	2.68e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—MTHFR—Alzheimer's disease	3.45e-06	2.68e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—LPL—Alzheimer's disease	3.36e-06	2.6e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TGFB1—Alzheimer's disease	3.36e-06	2.6e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6—Alzheimer's disease	3.28e-06	2.54e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—Alzheimer's disease	3.23e-06	2.51e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CALM1—Alzheimer's disease	3.23e-06	2.5e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—APOE—Alzheimer's disease	3.22e-06	2.49e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CAV1—Alzheimer's disease	3.19e-06	2.47e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—LPL—Alzheimer's disease	3.17e-06	2.45e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MTHFR—Alzheimer's disease	3.03e-06	2.34e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKT1—Alzheimer's disease	3.02e-06	2.34e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.85e-06	2.21e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CALM1—Alzheimer's disease	2.83e-06	2.19e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APOE—Alzheimer's disease	2.82e-06	2.18e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PPARG—Alzheimer's disease	2.8e-06	2.17e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CAV1—Alzheimer's disease	2.79e-06	2.16e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—Alzheimer's disease	2.76e-06	2.14e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—INS—Alzheimer's disease	2.75e-06	2.13e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—AKT1—Alzheimer's disease	2.73e-06	2.12e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.66e-06	2.06e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APOE—Alzheimer's disease	2.66e-06	2.06e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CAV1—Alzheimer's disease	2.63e-06	2.04e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6—Alzheimer's disease	2.53e-06	1.96e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PPARG—Alzheimer's disease	2.45e-06	1.9e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NOS3—Alzheimer's disease	2.41e-06	1.87e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—INS—Alzheimer's disease	2.41e-06	1.86e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT1—Alzheimer's disease	2.33e-06	1.81e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.31e-06	1.79e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—INS—Alzheimer's disease	2.27e-06	1.76e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS2—Alzheimer's disease	2.2e-06	1.71e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NOS3—Alzheimer's disease	2.11e-06	1.63e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.99e-06	1.54e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.93e-06	1.5e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.82e-06	1.41e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—AKT1—Alzheimer's disease	1.11e-06	8.58e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AKT1—Alzheimer's disease	9.7e-07	7.51e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AKT1—Alzheimer's disease	9.14e-07	7.08e-06	CbGpPWpGaD
